CNCR Fees and Costs — Range Cancer Therapeutics ETF
Data updated: 2025-04-28
The net expense ratio is 0.79%. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $29K in broker commissions, 0.1964% of average net assets, and portfolio turnover was 52%.
CNCR Fees and Expenses
Annual operating expenses and sales charges of CNCR. Prospectus, as of December 31, 2024.
| Annual operating expenses | |
|---|---|
| Management fee | 0.79% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.79% |
| Fee waiver | — |
| Net expense ratio | 0.79% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
CNCR Costs Over Time
On $10,000 invested in CNCR, assuming 5% a year before costs, total costs come to $617 over 5 years, cutting the return by 1.04% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.79%) | $83 | $259 | $449 |
| Trading costs (broker commissions) | $21 | $64 | $112 |
| Lost growth on money paid in costs | $0 | $16 | $57 |
| Total costs | $104 | $339 | $617 |
| Value after costs | $10,396 | $11,237 | $12,146 |
| Impact on return, per year | 1.04% | 1.04% | 1.04% |
CNCR Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.1964%
- Total broker commissions: $29K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 52%
- Securities lending: none during the year
CNCR Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | $22K | 75.00% |
| MISCHLER FINANCIAL GROUP, INC. | $3K | 11.87% |
| BTIG, LLC | $3K | 11.32% |
| GOLDMAN SACHS & CO. LLC | $523 | 1.81% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.